First, repurposing epigenetic drugs: Some existing epigenetic regulatory drugs (such as HDAC inhibitors, histone methyltransferase inhibitors, etc.)have been used in other diseases (Grandi and Bhutani, 2020) and could be tested for their effects in gout inflammation models. This evidence concerns the gene PRDM9 and gout.